inhibitory – Page 12 – Communicable Diseases Research

SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids

Research

Published on 2021-08-052022-10-30
Journal: Journal of Genetic Engineering & Biotechnology [Category] COVID-19,

NICEdrug.ch, a workflow for rational drug design and systems-level analysis of drug metabolism

Tools and Resources

Published on 2021-08-032022-10-31
Journal: eLife [Category] COVID-19,

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infection

시스템 수준의 연구에 따르면 SARS -COV -2 감염에 대한 숙주 대상 재구성 가능한 약물이 밝혀졌습니다.

Article

Published on 2021-08-022022-08-31
Journal: Molecular Systems Biology [Category] MERS, SARS, 신약개발, 유전자 메커니즘, 치료제,

[키워드] A549 A549 cell A549 cells activities Analysis antiviral activities antiviral activity approach autophagy brompheniramine Cell Cell fusion cells Chemical biology Compound connectivity COVID‐19 COVID‐19 patients disease drug drug candidate Effects exhibited Ezetimibe gene expression signature HEK293T hexylresorcinol host cells Hyperinflammatory response hyperinflammatory responses identify imipramine independent inhibitory linsitinib Map mechanism Microbiology, Virology & Host Pathogen Interaction mTOR mTOR inhibitor predicted Quantitative repertoire reveal rottlerin salmeterol SARS‐CoV‐2 SARS‐CoV‐2 infection SARS‐CoV‐2‐infected SARS‐CoV‐2‐infected cell transcriptomics screened small molecule Small molecules syncytia formation target host cell Therapeutics Transcriptome understanding Viral viral entry viral–host interactions
[DOI] 10.15252/msb.202110239 PMC 바로가기 [Article Type] Article

Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study

인도 인삼에 존재하는 파이토케미컬은 SARS-CoV-2 독성을 억제할 수 있는 잠재력을 가지고 있습니다: 분자 도킹 및 MD 시뮬레이션 연구

Article

Published on 2021-08-012022-09-11
Journal: Microbial pathogenesis [Category] SARS, 치료제,

[키워드] active site Affect anti-SARS-CoV-2 Antiviral antiviral agent Antiviral agents binding characteristic complex Compound contagious coronavirus drug target effective effort exhibited glucoside In silico studies in vitro in vivo inhibit SARS-CoV-2 inhibitor inhibitory Lopinavir M pro M(pro) MD simulation molecular docking molecular docking studies Molecular docking study molecular dynamics nelfinavir pathogen Pathogens phytochemical phytochemicals protease Protein protein-ligand quercetin rutin rutinoside SARS-CoV-2 silico studies simulation studies Simulation study trajectory Withania somnifera withanolide
[DOI] 10.1016/j.micpath.2021.104954 PMC 바로가기 [Article Type] Article

A novel nano therapeutic using convalescent plasma derived exosomal (CP Exo) for COVID-19: A combined hyperactive immune modulation and diagnostics

COVID-19에 대한 회복기 혈장 유래 엑소좀(CP Exo)을 사용한 새로운 나노 치료제: 과민성 면역 조절 및 진단 결합

Article

Published on 2021-08-012022-09-12
Journal: Chemico-biological interactions [Category] MERS, SARS, 바이오마커, 신약개발, 진단, 치료제,

CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy

Covitris2020 및 Chlovid2020 : Covid-19 치료에서 놀라운 새로운 희망

Article

Published on 2021-08-012022-08-31
Journal: Molecular diversity [Category] 신약개발, 치료제,

[키워드] activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Anti-COVID-19 drug anti-SARS-CoV-2 antioxidant binding affinities binding affinity binding energy biological assay blocker ChloViD2020 Clinical studies Compound Coronaviral Coronaviral-2 coronavirus COVID-19 COVID-19 therapy CoViTris2020 derivative disease docked docking drug Drug discovery effective enzyme exhibited Favipiravir in vitro inhibit inhibit SARS-CoV-2 inhibitory Ivermectin lead life cycle Ligand lower binding energy medication molecular docking oxadiazole Papain Papain-like protease Papain-like protease (PLpro) PLPro Polyphenolic 2,5-disubstituted-1,3,4-oxadiazole protease Protein RdRP Remdesivir repurposing required Research respiratory RNA polymerase RNA-dependent RNA polymerase RNA-dependent RNA polymerase (RdRp) robust SARS-CoV-2 SARS-CoV-2 life cycle SARS-CoV-2 proteins severe acute respiratory syndrome Coronavirus significantly the SARS-CoV-2 therapy
[DOI] 10.1007/s11030-020-10169-0 PMC 바로가기 [Article Type] Article

Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19

분자 도킹, 결합 모드 분석, 분자 역학 및 SARS-COV-2 주요 프로테아제에 대한 선택적 전위 항 바이러스제의 ADMET/독성 특성의 예측 : CovID-19에 대항하기위한 약물 용도를 향한 노력

Article

Published on 2021-08-012022-08-31
Journal: Molecular diversity [Category] SARS, 신약개발, 치료제,

[키워드] active site Amino acid amino acid residue amino acid residues Analysis Antiviral antiviral agent Antiviral agents antiviral drug antiviral molecules ARB Arbidol AutoDock binding carried Chloroquine complex COVID-19 crystal structure Cys145 digestion direction docking Docking studies docking study drug design Drug discovery drug target Dynamics/simulation study effort enzyme exhibited FDA-approved drug FDA-approved drugs Glu166 glycyrrhizin GS441524 HCQ HIS163 Hydroxychloroquine in silico indicated inhibitory Interaction lead Ligand M pro mechanism molecular molecular docking molecular docking studies Molecular docking study molecular dynamics molecules MPro not need polyprotein Potential Potential antiviral agents present protease Protein provide RDV reason reason for Remdesivir RMSD SARS-CoV-2 SARS-CoV-2 main protease SARS-CoV-2 main protease (Mpro). selected selective stability starting point starting points suggested tested Toxicity Viral
[DOI] 10.1007/s11030-021-10188-5 PMC 바로가기 [Article Type] Article

Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection

렘데시비르와 이버멕틴의 병용 치료는 쥐 코로나바이러스 감염에 대해 높은 시너지 효과와 강력한 항바이러스 활성을 나타냅니다.

Cellular and Infection Microbiology

Published on 2021-07-302022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 치료제,

[키워드] activity Against antiviral drug antiviral therapy Betacoronavirus Betacoronavirus genus both viruses Cell Chloroquine clinical clinical trial clinical trials Combination combination therapy combination treatment coronavirus COVID-19 COVID-19 pandemic cytokine level develop doxycycline drug drug therapy effective Efficacy evaluated exhibited Hepatitis highest IC50 IL-6 in vitro model in vivo experiment indicated infect Infection inhibitory investigated Ivermectin ivermectin treatment leukemia Live virus lowest Macrophage macrophages mechanism MHV mice monotherapy murine hepatitis virus potent RAW264.7 macrophage cells reduction Remdesivir Replication Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections selectivity index sequence identity significant reductions synergism synergistic tested the Betacoronavirus the disease therapy TNF-α Treatment Trial urgency viability Viral Viral RNA virus viruses
[DOI] 10.3389/fcimb.2021.700502 PMC 바로가기 [Article Type] Cellular and Infection Microbiology

Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study

Article

Published on 2021-07-292022-10-28
Journal: Pharmaceuticals [Category] COVID-19,

[키워드] Polygoni cuspidati rhizoma Reynoutria sachalinensis acute lung injury acute respiratory syndrome antiviral activity binding site butanol China Chinese Compound coronavirus Coronavirus disease 2019 COVID-19 COVID-19 (Coronavirus disease 2019) docked drug Effect emodin explain fluorescent food fraction Fractions gallate H1N1 identify in vitro inhibitory moderate natural pandemic Patient peptide plant polymerized Prevent Proanthocyanidins provide Replication Research responsible resveratrol rhizome SARS-CoV-2 SARS-CoV-2 main protease SARS-CoV-2 Mpro Shu Source Spread Supportive treatment TCM tested Traditional treat Treatment vanicoside virus
[DOI] 10.3390/ph14080742 PMC 바로가기 [Article Type] Article

S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study

Article

Published on 2021-07-262022-10-29
Journal: Scientific Reports [Category] COVID-19, SARS,